Funded Tech Companies
Wilson Therapeutics
Wondering who backed Wilson Therapeutics? Healthcap Venture Capital and Abingworth joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Wilson Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1500 District Ave.
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Wilson Therapeutics AB is a privately-held biopharmaceutical company focused on developing novel treatments for Wilson Disease, a rare genetic disease that affects approximately 1 in 15,000. Wilson Therapeutics was founded in 2012 and is backed by HealthCap, one of the leading European life science venture capital funds.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/17/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonas Hansson
Chief Financial Officer
Anders Martin-Löf
Chief Medical Officer
Carl Bjartmar
Chief Scientific Officer
Thomas Plitz
VP - Manufacturing
Lars Olsson
Company Investors
- Healthcap Venture Capital
- Abingworth (Genghis Lloyd-Harris)
Browse more funded tech companies:
Wilshire Axon Sports | Wilson TurboPower
Share this article
About Our VC Transaction Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs